AC T10399
XX
ID T10399
XX
DT 10.03.2005 (created); nvo.
DT 10.12.2014 (updated); pro.
CO Copyright (C), QIAGEN.
XX
FA NF-kappaB1-p50
XX
SY 243/NFA-kappaB; EBP-1; H2TF1; HeLa B factor; KBF1; NF-kappaB (p50); NF-kappaB1; NFKB-p50; Nuclear Factor kappa B p50; p110; p50; TC-IIB.
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
IN T08796 ASC-2; human, Homo sapiens.
IN T08910 Bcl-3; human, Homo sapiens.
IN T08664 C/EBPalpha; Mammalia.
IN T08709 egr-3-isoform1; human, Homo sapiens.
IN T08705 Egr-4; human, Homo sapiens.
IN T22238 egr3; Mammalia.
IN T08988 Elf-1-isoform1; human, Homo sapiens.
IN T10659 Elf-1; Mammalia.
IN T08300 ER-alpha-L; human, Homo sapiens.
IN T21852 HDAC1; Mammalia.
IN T10639 HMGIY; Mammalia.
IN T05894 NRF-isoform1; human, Homo sapiens.
IN T09963 PPARgamma; Mammalia.
IN T10397 RelA-p65; Mammalia.
IN T14321 RelA-p65; Mammalia.
IN T08256 SRC-1A; human, Homo sapiens.
IN T17428 TFIIB; Mammalia.
XX
MX M03557 V$P50_Q6.
XX
BS R30571.
BS R25603.
BS R00702.
BS R27918.
BS R24146.
BS R21039.
BS R12092.
BS R30568.
BS R30570.
BS R65202.
BS R30143.
BS R29805.
BS R32701.
BS R32704.
BS R32705.
BS R37979.
BS R37993.
BS R19783.
BS R36880.
BS R24686.
BS R29217.
BS R74069.
BS R74068.
BS R30627.
BS R57555.
BS R08131.
BS R21225.
BS R24784.
BS R32894.
BS R55836.
BS R14446.
BS R08469.
BS R26644.
BS R40880.
BS R22559.
BS R21681.
BS R21683.
BS R30716.
BS R04905.
XX
DR TRANSPATH: MO000047051.
DR TRANSCOMPEL: C00235.
DR TRANSCOMPEL: C00258.
DR TRANSCOMPEL: C00305.
DR TRANSCOMPEL: C00308.
DR TRANSCOMPEL: C00326.
DR TRANSCOMPEL: C00328.
DR TRANSCOMPEL: C00329.
DR TRANSCOMPEL: C00332.
DR TRANSCOMPEL: C00346.
DR TRANSCOMPEL: C00350.
DR TRANSCOMPEL: C00611.
XX
RN [1]; RE0004538.
RX PUBMED: 8458581.
RA Mercurio F., Didonato J. A., Rosette C., Karin M.
RT p105 and p98 precursor proteins play an active role in NF-kappaB-mediated signal transduction
RL Genes Dev. 7:705-718 (1993).
RN [2]; RE0015392.
RX PUBMED: 10777532.
RA Lee S. K., Kim J. H., Lee Y. C., Cheong J., Lee J. W.
RT Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor
RL J. Biol. Chem. 275:12470-12474 (2000).
RN [3]; RE0024011.
RX PUBMED: 10357819.
RA Yie J., Merika M., Munshi N., Chen G., Thanos D.
RT The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
RL EMBO J. 18:3074-3089 (1999).
RN [4]; RE0024028.
RX PUBMED: 10562553.
RA Nourbakhsh M., Hauser H.
RT Constitutive silencing of IFN-beta promoter is mediated by NRF (NF-kappaB-repressing factor), a nuclear inhibitor of NF-kappaB.
RL EMBO J. 18:6415-6425 (1999).
RN [5]; RE0028144.
RX PUBMED: 10362352.
RA Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn F. G., Scheidereit C., Leutz A.
RT The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
RL Oncogene 18:3316-23 (1999).
RN [6]; RE0047425.
RX PUBMED: 16014385.
RA Wieland G. D., Nehmann N., Muller D., Eibel H., Siebenlist U., Suhnel J., Zipfel P. F., Skerka C.
RT Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65.
RL J. Cell Sci. 118:3203-3212 (2005).
RN [7]; RE0047427.
RX PUBMED: 9556555.
RA Na S. Y., Lee S. K., Han S. J., Choi H. S., Im S. Y., Lee J. W.
RT Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations.
RL J. Biol. Chem. 273:10831-10834 (1998).
RN [8]; RE0047851.
RX PUBMED: 10847592.
RA Lee S. K., Na S. Y., Jung S. Y., Choi J. E., Jhun B. H., Cheong J., Meltzer P. S., Lee Y. C., Lee J. W.
RT Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2.
RL Mol. Endocrinol. 14:915-925 (2000).
RN [9]; RE0048086.
RX PUBMED: 11526476.
RA Heppner C., Bilimoria K. Y., Agarwal S. K., Kester M., Whitty L. J., Guru S. C., Chandrasekharappa S. C., Collins F. S., Spiegel A. M., Marx S. J., Burns A. L.
RT The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation.
RL Oncogene 20:4917-4925 (2001).
RN [10]; RE0048551.
RX PUBMED: 16254192.
RA Paz-Priel I., Cai D. H., Wang D., Kowalski J., Blackford A., Liu H., Heckman C. A., Gombart A. F., Koeffler H. P., Boxer L. M., Friedman A. D.
RT CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
RL Mol. Cancer Res. 3:585-596 (2005).
RN [11]; RE0052059.
RX PUBMED: 11931769.
RA Zhong H., May M. J., Jimi E., Ghosh S.
RT The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.
RL Mol. Cell 9:625-636 (2002).
RN [12]; RE0053748.
RX PUBMED: 12871932.
RA Demarchi F., Bertoli C., Sandy P., Schneider C.
RT Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability.
RL J. Biol. Chem. 278:39583-39590 (2003).
RN [13]; RE0054190.
RX PUBMED: 12820969.
RA Saccani S., Pantano S., Natoli G.
RT Modulation of NF-kappaB activity by exchange of dimers.
RL Mol. Cell 11:1563-1574 (2003).
XX
//